跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
JUBREXA ORODISPERSIBLE TABLET 5MG - HSA Drug Approval Details
Approvals
/
HSA
/
JUBREXA ORODISPERSIBLE TABLET 5MG
Approved
THERAPEUTIC
JUBREXA ORODISPERSIBLE TABLET 5MG
JUBILANT GENERICS LIMITED (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
May 28, 2018
Approval ID
52a569d22daba7ce
Company
JUBILANT GENERICS LIMITED (INDIA)
Type
Therapeutic
Approval Details
Approval Id
52a569d22daba7ce
Drug Name
JUBREXA ORODISPERSIBLE TABLET 5MG
Product Name
JUBREXA ORODISPERSIBLE TABLET 5MG
Approval Number
SIN15495P
Approval Date
2018-05-28
Registrant
UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED
Licence Holder
UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route Of Administration
ORAL
Atc Code
N05AH03
Atc Item Name
olanzapine
Pharma Manufacturer Name
GOLDPLUS UNIVERSAL PTE LTD
Active Ingredients
Olanzapine
5mg
Olanzapine
5mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 28, 2018
Approval ID
52a569d22daba7ce
Type
Therapeutic
Back to HSA Approvals